Basilea Pharmaceutica Ltd. reported that shareholders approved all agenda items proposed at Ordinary General Meeting of Shareholders for the financial year 2012. Dr. Martin Nicklasson was elected to the Board of Directors for a term of three years. The Board of Directors elected Dr. Nicklasson as Chairman of the Board and Domenico Scala as Vice-Chairman.

The company also announced the retiring Board members Werner Henrich, Chairman since the company's inception, and Claude Schreiner, Board Member since 2007.